Elite Pharmaceuticals, Inc. (ELTP)
0.2475
0.00 (0.00%)
USD |
OTCM |
Sep 18, 16:00
Elite Pharmaceuticals Total Long Term Debt (Quarterly) : 5.019M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.019M |
| March 31, 2026 | 5.279M |
| December 31, 2025 | 5.537M |
| September 30, 2025 | 5.793M |
| June 30, 2025 | 6.187M |
| March 31, 2025 | 6.442M |
| December 31, 2024 | 6.720M |
| September 30, 2024 | 6.974M |
| June 30, 2024 | 7.247M |
| March 31, 2024 | 7.326M |
| December 31, 2023 | 3.862M |
| September 30, 2023 | 3.650M |
| June 30, 2023 | 3.830M |
| March 31, 2023 | 3.872M |
| December 31, 2022 | 15.96M |
| September 30, 2022 | 16.04M |
| June 30, 2022 | 14.42M |
| March 31, 2022 | 2.579M |
| December 31, 2021 | 2.767M |
| September 30, 2021 | 2.923M |
| June 30, 2021 | 3.251M |
| March 31, 2021 | 2.190M |
| December 31, 2020 | 4.447M |
| September 30, 2020 | 4.531M |
| June 30, 2020 | 4.819M |
| Date | Value |
|---|---|
| March 31, 2020 | 3.820M |
| December 31, 2019 | 3.732M |
| September 30, 2019 | 3.852M |
| June 30, 2019 | 4.102M |
| March 31, 2019 | 3.980M |
| December 31, 2018 | 3.986M |
| September 30, 2018 | 3.799M |
| June 30, 2018 | 3.998M |
| March 31, 2018 | 3.986M |
| December 31, 2017 | 3.841M |
| September 30, 2017 | 3.757M |
| June 30, 2017 | 3.882M |
| March 31, 2017 | 2.649M |
| December 31, 2016 | 2.534M |
| September 30, 2016 | 2.392M |
| June 30, 2016 | 2.619M |
| March 31, 2016 | 2.373M |
| December 31, 2015 | 2.065M |
| September 30, 2015 | 2.065M |
| June 30, 2015 | 2.51M |
| March 31, 2015 | 2.540M |
| December 31, 2014 | 34.56M |
| September 30, 2014 | 48.16M |
| June 30, 2014 | 4.092M |
| March 31, 2014 | 64.90M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Nektar Therapeutics | 113.23M |
| Daré Bioscience, Inc. | 6.169M |
| Eton Pharmaceuticals, Inc. | 28.99M |
| ANI Pharmaceuticals, Inc. | 610.49M |
| Corcept Therapeutics, Inc. | 7.504M |